Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
801 On Other Exchanges
801 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

golden meditech holdings ltd (801) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GOLDEN MEDITECH HOLDINGS LTD (801)

Related News

No related news articles were found.

golden meditech holdings ltd (801) Related Businessweek News

No Related Businessweek News Found

golden meditech holdings ltd (801) Details

Golden Meditech Holdings Limited, an investment holding company, operates as an integrated healthcare enterprise in the People’s Republic of China. It operates through five segments: Medical Devices, Cord Blood Storage, Hospital Management, Medical Insurance Administration, and Chinese Herbal Medicines. The Medical Devices segment develops, manufactures, and sells medical devices and medical accessories. This segment also offers blood related medical devices, such as Autologous Blood Recovery System and its consumables. The Cord Blood Bank segment provides cord blood stem cell examination, processing, separation, storage, and other related services. The Hospital Management segment offers management services to hospitals. This segment also provides premium healthcare services; and operates a hospital, which specializes in hematology. The Medical Insurance Administration segment offers medical insurance administration services. This segment also provides claim processing and bill settlement services to medical insurance companies, hospitals, and policy holders. The Chinese Herbal Medicine segment is involved in the research, development, manufacture, and sale of Chinese herbal medicines. The company was formerly known as Golden Meditech Company Limited and changed its name to Golden Meditech Holdings Limited in March 2010. Golden Meditech Holdings Limited was incorporated in 2001 and is headquartered in Beijing, the People’s Republic of China.

1,661 Employees
Last Reported Date: 06/30/15
Founded in 2001

golden meditech holdings ltd (801) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, C...
Total Annual Compensation: $2.6M
Chief Operating Officer and Executive Directo...
Total Annual Compensation: $5.4M
Company Secretary, Executive Director and Mem...
Total Annual Compensation: $3.7M
Total Annual Compensation: $555.0K
Compensation as of Fiscal Year 2015.

golden meditech holdings ltd (801) Key Developments

Nanjing Xinjiekou Likely To Win Bid For China Cord Blood

Nanjing Xinjiekou Department Store Co., Ltd. (SHSE:600682) is having increasing odds to win the bid on China Cord Blood Corporation (NYSE:CO) among a number of candidates. On August 26, 2015, five listed companies involved in the bid filed announcements respectively, together giving a clear picture of the takeover fight which is heading into the homestretch. Zhongyuan Union Cell & Gene Engineering Corp., Ltd had announced its plan to acquire a minority equity interest of China Cord. On August 26, 2015, Nanjing Xinjiekou published an announcement which said that it was in talks with China Cord's major shareholder Golden Meditech Holdings Limited (SEHK:801) about the acquisition of China Cord's assets and equity interests.

Golden Meditech Holdings Limited, Annual General Meeting, Jul 31, 2015

Golden Meditech Holdings Limited, Annual General Meeting, Jul 31, 2015., at 10:00 China Standard Time. Location: No. 4 Yong Chang North Road. Agenda: To consider and adopt the audited consolidated financial statements of the Company and its subsidiaries and the reports of the directors of the company and of the auditors for the year ended 31 March 2015; to declare a final dividend (with scrip option) for the year ended 31 March 2015; to re-elect directors; to authorise the board of Directors to fix the Directors' remuneration; to re-appoint the retiring auditors, KPMG, and to authorise the Board to fix their remuneration; and to consider increase in authorised share capital of the company.

Golden Meditech Holdings Limited Announces Financial Results for the Year Ended March 31, 2015

Golden Meditech Holdings Limited announced financial results for the year ended March 31, 2015. For the year, the company reported turnover of HKD 1,051,350,000 against HKD 1,085,068,000 a year ago. Loss after tax was HKD 881,437,000 against HKD 712,864,000 a year ago. Adjusted profit after tax was HKD 147,616,000 against HKD 141,133,000 a year ago. Loss attributable to equity shareholders was HKD 805,860,000 or 46.3 cents per basic and diluted share against HKD 429,081,000 or 33.6 cents per diluted share a year ago. Adjusted attributable to equity shareholders was HKD 29,885,000 or 1.7 cents per basic share against HKD 86,464,000 or 6.8 cents per basic share a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
801:HK $1.00 HKD +0.01

801 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 801.
View Industry Companies

Industry Analysis


Industry Average

Valuation 801 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.7x
Price/Book 0.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GOLDEN MEDITECH HOLDINGS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at